Cargando…
Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413014/ https://www.ncbi.nlm.nih.gov/pubmed/37577318 http://dx.doi.org/10.21037/tlcr-23-245 |
| _version_ | 1785087042092269568 |
|---|---|
| author | Cali Daylan, Ayse Ece Halmos, Balazs |
| author_facet | Cali Daylan, Ayse Ece Halmos, Balazs |
| author_sort | Cali Daylan, Ayse Ece |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10413014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104130142023-08-11 Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail Cali Daylan, Ayse Ece Halmos, Balazs Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-05-31 2023-07-31 /pmc/articles/PMC10413014/ /pubmed/37577318 http://dx.doi.org/10.21037/tlcr-23-245 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Cali Daylan, Ayse Ece Halmos, Balazs Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title | Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title_full | Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title_fullStr | Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title_full_unstemmed | Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title_short | Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| title_sort | long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413014/ https://www.ncbi.nlm.nih.gov/pubmed/37577318 http://dx.doi.org/10.21037/tlcr-23-245 |
| work_keys_str_mv | AT calidaylanayseece longtermbenefitofimmunotherapyinmetastaticnonsmallcelllungcancerthetaleofthetail AT halmosbalazs longtermbenefitofimmunotherapyinmetastaticnonsmallcelllungcancerthetaleofthetail |